tiprankstipranks
Haemonetics Corp. (HAE)
NYSE:HAE

Haemonetics (HAE) Financial Statements

329 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently ―. The company's EPS TTM is $2.465; its P/E ratio is 33.12; Haemonetics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $0.89. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Apr 23Dec 22
Income Statement-
Total Revenue$ 336.25M$ 318.18M$ 311.33M-$ 305.30M
Gross Profit$ 177.87M$ 170.51M$ 167.26M-$ 158.71M
EBIT$ 44.03M$ 32.83M$ 51.59M-$ 42.22M
EBITDA$ 68.34M$ 56.63M$ 75.45M-$ 50.30M
Net Income Common Stockholders$ 31.24M$ 39.40M$ 41.04M-$ 32.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 193.98M$ 351.00M$ 285.72M$ 284.47M$ 224.00M
Total Assets$ 2.20B$ 2.01B$ 1.96B$ 1.93B$ 1.88B
Total Debt$ 870.59M$ 762.23M$ 764.95M$ 765.89M$ 766.77M
Net Debt$ 676.61M$ 411.22M$ 479.23M$ 481.42M$ 542.77M
Total Liabilities$ 1.26B$ 1.12B$ 1.10B$ 1.12B$ 1.10B
Stockholders Equity$ 943.32M$ 893.66M$ 864.62M$ 818.00M$ 775.98M
Cash Flow-
Free Cash Flow$ -22.50M$ 72.12M$ 12.70M$ 66.49M$ 44.76M
Operating Cash Flow$ -540.00K$ 96.25M$ 21.96M$ 84.49M$ 61.45M
Investing Cash Flow$ -268.94M$ -25.14M$ -15.26M$ -18.51M$ -36.00M
Financing Cash Flow$ 109.43M$ -4.30M$ -3.47M$ -5.98M$ -47.22M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis